296 related articles for article (PubMed ID: 33183734)
1. Updates in Pediatric Glioma Pathology.
Hakar MH; Wood MD
Surg Pathol Clin; 2020 Dec; 13(4):801-816. PubMed ID: 33183734
[TBL] [Abstract][Full Text] [Related]
2. Histologic classification of gliomas.
Perry A; Wesseling P
Handb Clin Neurol; 2016; 134():71-95. PubMed ID: 26948349
[TBL] [Abstract][Full Text] [Related]
3. Progress in the application of molecular biomarkers in gliomas.
Wang J; Su HK; Zhao HF; Chen ZP; To SS
Biochem Biophys Res Commun; 2015 Sep; 465(1):1-4. PubMed ID: 26253473
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Glial Tumors.
Viaene AN; Santi M; Hawkins C
Pediatr Dev Pathol; 2022; 25(1):46-58. PubMed ID: 33872106
[TBL] [Abstract][Full Text] [Related]
5. Molecular Classification of Diffuse Gliomas.
Kalidindi N; Or R; Babak S; Mason W
Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
[TBL] [Abstract][Full Text] [Related]
6. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
7. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
[TBL] [Abstract][Full Text] [Related]
8. Characterization of gliomas: from morphology to molecules.
Ferris SP; Hofmann JW; Solomon DA; Perry A
Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742
[TBL] [Abstract][Full Text] [Related]
9. [Classification of gliomas. Current progress and perspectives].
Capper D; Reifenberger G
Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
[TBL] [Abstract][Full Text] [Related]
10. Current concepts in the pathology and genetics of gliomas.
Sarkar C; Jain A; Suri V
Indian J Cancer; 2009; 46(2):108-19. PubMed ID: 19346644
[TBL] [Abstract][Full Text] [Related]
11. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
Malzkorn B; Reifenberger G
Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
[TBL] [Abstract][Full Text] [Related]
12. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
[TBL] [Abstract][Full Text] [Related]
13. [Tumor progression of diffuse median glioma with H3 K27 alteration from pilocytic astrocytoma to glioblastoma].
Zabrodskaya YM; Sidorin VS; Nikolaenko MS; Samochernikh KA
Arkh Patol; 2022; 84(6):40-46. PubMed ID: 36469716
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.
Jacobs DI; Fukumura K; Bainbridge MN; Armstrong GN; Tsavachidis S; Gu X; Doddapaneni HV; Hu J; Jayaseelan JC; Muzny DM; Huse JT; Bondy ML
Neuro Oncol; 2018 Nov; 20(12):1625-1633. PubMed ID: 30165405
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis to complement histopathological diagnosis of brain tumors.
Nakamura M; Shimada K; Ishida E; Nakase H; Konishi N
Histol Histopathol; 2007 Mar; 22(3):327-35. PubMed ID: 17163407
[TBL] [Abstract][Full Text] [Related]
16. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
[TBL] [Abstract][Full Text] [Related]
17. Adult Glioma WHO Classification Update, Genomics, and Imaging: What the Radiologists Need to Know.
Bai J; Varghese J; Jain R
Top Magn Reson Imaging; 2020 Apr; 29(2):71-82. PubMed ID: 32271284
[TBL] [Abstract][Full Text] [Related]
18. Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis.
Erson-Omay EZ; Çağlayan AO; Schultz N; Weinhold N; Omay SB; Özduman K; Köksal Y; Li J; Serin Harmancı A; Clark V; Carrión-Grant G; Baranoski J; Çağlar C; Barak T; Coşkun S; Baran B; Köse D; Sun J; Bakırcıoğlu M; Moliterno Günel J; Pamir MN; Mishra-Gorur K; Bilguvar K; Yasuno K; Vortmeyer A; Huttner AJ; Sander C; Günel M
Neuro Oncol; 2015 Oct; 17(10):1356-64. PubMed ID: 25740784
[TBL] [Abstract][Full Text] [Related]
19. [Towards a molecular classification of gliomas].
Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
[TBL] [Abstract][Full Text] [Related]
20. [Current classification of gliomas].
Taillibert S; Pedretti M; Sanson M
Presse Med; 2004 Oct; 33(18):1274-7. PubMed ID: 15611709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
